Parallel Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$99.9K Buy
1,768
+448
+34% +$26.1K ﹤0.01% 1591
2025
Q4
$78.4K Buy
1,320
+551
+72% +$30K ﹤0.01% 1603
2025
Q3
$41.6K Buy
769
+295
+62% +$16.9K ﹤0.01% 1881
2025
Q2
$26K Sell
474
-861
-64% -$50.7K ﹤0.01% 2070
2025
Q1
$94.4K Buy
1,335
+660
+98% +$44.4K ﹤0.01% 1301
2024
Q4
$44.4K Sell
675
-395
-37% -$26.5K ﹤0.01% 1698
2024
Q3
$75.2K Sell
1,070
-1,064
-50% -$88.9K ﹤0.01% 1405
2024
Q2
$176K Sell
2,134
-233
-10% -$19.4K ﹤0.01% 923
2024
Q1
$207K Buy
2,367
+169
+8% +$15.1K 0.01% 843
2023
Q4
$212K Sell
2,198
-154
-7% -$13.6K 0.01% 772
2023
Q3
$208K Sell
2,352
-3,062
-57% -$272K 0.01% 771
2023
Q2
$469K Sell
5,414
-604
-10% -$56.8K 0.02% 486
2023
Q1
$585K Buy
6,018
+1,046
+21% +$108K 0.02% 415
2022
Q4
$515K Buy
4,972
+439
+10% +$41.2K 0.02% 399
2022
Q3
$384K Buy
4,533
+3,289
+264% +$293K 0.02% 463
2022
Q2
$103K Buy
1,244
+29
+2% +$2.31K ﹤0.01% 946
2022
Q1
$95K Sell
1,215
-262
-18% -$21.9K ﹤0.01% 1007
2021
Q4
$130K Buy
1,477
+750
+103% +$61.9K ﹤0.01% 904
2021
Q3
$56K Buy
727
+32
+5% +$2.52K ﹤0.01% 1224
2021
Q2
$58K Buy
695
+117
+20% +$9.28K ﹤0.01% 1179
2021
Q1
$44K Hold
578
﹤0.01% 1234
2020
Q4
$51K Sell
578
-125
-18% -$9.91K ﹤0.01% 1084
2020
Q3
$53K Buy
703
+221
+46% +$22.4K ﹤0.01% 1041
2020
Q2
$59K Buy
482
+75
+18% +$7.45K ﹤0.01% 978
2020
Q1
$34K Buy
407
+33
+9% +$2.84K ﹤0.01% 1077
2019
Q4
$32K Hold
374
﹤0.01% 1197
2019
Q3
$25K Buy
374
+21
+6% +$1.62K ﹤0.01% 1253
2019
Q2
$30K Sell
353
-65
-16% -$5.56K ﹤0.01% 1102
2019
Q1
$37K Sell
418
-57
-12% -$5.28K ﹤0.01% 954
2018
Q4
$40K Sell
475
-3,003
-86% -$286K 0.01% 831
2018
Q3
$337K Buy
3,478
+500
+17% +$49.9K 0.04% 276
2018
Q2
$280K Buy
2,978
+1,993
+202% +$175K 0.04% 276
2018
Q1
$80K Sell
985
-51
-5% -$4.38K 0.01% 565
2017
Q4
$92K Buy
1,036
+44
+4% +$3.83K 0.02% 509
2017
Q3
$80K Sell
992
-36
-4% -$3.18K 0.01% 536
2017
Q2
$90K Sell
1,028
-14
-1% -$1.27K 0.02% 502
2017
Q1
$100K Buy
1,042
+125
+14% +$11.1K 0.02% 441
2016
Q4
$76K Buy
+917
New +$78.9K 0.02% 455

Other funds holding BMRN